Charles Nelson joins Malaria Consortium from Merlin (Medical Emergency Relief International) where, as International Director, he was responsible for the delivery, through over 5000 staff in 16 countries, of directly-implemented, health- and nutrition-focused aid to vulnerable, and in many cases, malaria-impacted populations. He joined the sector following nearly 30 years of experience in health systems, international business leadership and strategy consulting with a particular focus on healthcare systems and organisations. Immediately prior to joining Merlin he operated as an independent consultant, primarily supporting change in and across the UK National Health Service, working extensively with governance and evidence organizations including Strategic Health Authorities, Primary Care Trusts, Provider organizations, Specialised Commissioning and the National Information Centre for Health and Social Care. As Global Head of Strategy and Markets’ Development for Mercer’s Health and Benefits’ business (part of the Marsh McClennan Corporation – MMC), Charles worked with major corporations and Government agencies around the world, launching and supporting emerging businesses particularly focused on health care financing. Charles also spent 7 years with McKinsey & Company working on major strategy and change projects in the Healthcare and ‘Not-for-Profit’ sectors. A scientist by training, he began his career with 14 years in Operations/Logistics with various technical and line management roles with, among others; L’Oreal, GlaxoSmithkline, Northern Foods and Nabisco, including the manufacturing and distribution of medical and food products.
In February 2022, it was announced that Charles Nelson would step down as Chief Executive in October 2022.